Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study-Reference-Cited by-同舟云学术

Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study

Published:2010-10 Issue:10 Volume:117 Page:1974-1981.e1
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Arevalo J. Fernando,Sánchez Juan G.,Wu Lihteh,Berrocal Maria H.,Alezzandrini Arturo A.,Restrepo Natalia,Maia Mauricio,Farah Michel E.,Brito Miguel,Díaz-Llopis Manuel,Rodríguez Francisco J.,Reategui Guillermo,Iturralde-Iraola Juan,Udaondo-Mirete Patricia

Publisher

Elsevier BV

Subject

Ophthalmology

Reference35 articles.

1. Diseases of the retina;D'Amico;N Engl J Med,1994

2. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11;Arch Ophthalmol,2003

3. The epidemiology of age-related macular degeneration;Klein;Am J Ophthalmol,2004

4. Causes and prevalence of visual impairment among adults in the United States;Arch Ophthalmol,2004

5. Prevalence of age-related macular degeneration in the United States;Arch Ophthalmol,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression;Journal of Clinical Medicine;2022-01-10

2. TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands;BMJ Open Ophthalmology;2020-12

3. Real-world outcomes of intravitreal anti-vascular endothelial growth factor monotherapy in proliferative type 2 macular telangiectasia;Graefe's Archive for Clinical and Experimental Ophthalmology;2020-11-17

4. A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration;BMC Ophthalmology;2020-01-09